However, HIF-1α can also remain stable in normoxia in malignant cancer cells or after some treatment, namely pseudohypoxia, which is defined as a phenomenon in which many cancer cells have developed the ability to activate and utilize hypoxia-dependent pathways even in the presence of oxygen [7]. The gene discussed is HIF1A; the disease is cancer.